DASHBOARD: Oncology At A Glance

Oncology

May 2024

Markets: US, France, Germany, Italy, Spain, UK

With so many tumour types and so many products licensed to treat them, conducting desk research to compile information about oncology products in your indication of interest can be daunting ‑ and that’s why we’ve done the work for you.

Ipsos’ ’Oncology at a Glance’ dashboard brings together the key facts about more than 200 branded/exclusive oncology drug products commercially available in the US, UK & EU4. The intuitive Tableau user interface, combined with easy-to-use drop-down options for specific categories, allows you to hone in on the market metrics relevant to your business.

In summary, precision information on one screen.

  • Brand and molecule name, therapy class / biomarker, manufacturer
  • Indication ‑ tumour, patient type, therapy line, etc.
  • Approval date (by indication), order of entry
  • Route of administration and regimen type

  • Contains information for over 200 oncology treatment products
  • Includes 1 Tableau user licence and regular information updates
  • Curated by Ipsos’ dedicated Oncology experts
Example screen of dashboard highlighting categories available for users to filter on to receive cancer drug information

Sample excerpt from dashboard

  • Data collection timeframe: Updated monthly
  • Data source: Secondary research – FDA and EMA approvals
  • Regions shown: US; Aggregate of France, Germany, Italy, Spain, UK
  • Purchase includes: 1 Tableau user licence
Speak to the team